UBS Maintains Neutral on Lineage, Raises Price Target to $45

Lineage, Inc.

Lineage, Inc.

LINE

0.00

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ: LINE) with a Neutral and raises the price target from $35 to $45.